CALL/TEVA PHARMACEUTICAL INDUSTRIES/10/1/16.01.26 Share Price

Warrant

DE000GG22526

Real-time BOERSE MUENCHEN 19:27:09 25/06/2024 BST
7.34 EUR -0.27% Intraday chart for CALL/TEVA PHARMACEUTICAL INDUSTRIES/10/1/16.01.26
Current month-2.91%
1 month-1.61%
Date Price Change
25/06/24 7.34 -0.27%
24/06/24 7.36 -4.79%
21/06/24 7.73 -0.64%
20/06/24 7.78 -0.13%
19/06/24 7.79 -0.51%

Real-time BOERSE MUENCHEN

Last update June 25, 2024 at 07:27 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer Goldman Sachs
WKN GG2252
ISINDE000GG22526
Date issued 22/01/2024
Strike 10 $
Maturity 16/01/2026 (570 Days)
Parity 1 : 1
Emission price 3.07
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 8.12
Lowest since issue 3.36
Delta0.9x
Omega 1.878
Premium8.42x
Gearing2.09x
Moneyness 1.650
Difference Strike -6.5 $
Difference Strike %-65.00%
Spread 0.05
Spread %0.68%
Theoretical value 7.390
Implied Volatility 48.41 %
Total Loss Probability 25.58 %
Intrinsic value 6.069
Present value 1.321
Break even 17.92 €
Theta-0.02x
Vega0.03x
Rho0.1x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.5 USD
Average target price
18.34 USD
Spread / Average Target
+11.13%
Consensus